Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating therapeutic drug monitoring-guided de-escalation of adalimumab in non-infectious chronic uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Uveitis, Chronic Disease | Phase 4 | Status: NOT_YET_RECRUITING